Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas

Clinical trial NCT00704691 · TERMINATED

Trial details

NCT number: NCT00704691
Sponsor: University of Alabama at Birmingham
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Peripheral T-cell Lymphomas Adult T-cell Leukemia Adult T-cell Lymphoma Peripheral T-cell Lymphoma Unspecified Angioimmunoblastic T-cell Lymphoma Anaplastic Large Cell Lymphoma T/Null Cell Systemic Type Cutaneous t-Cell Lymphoma With Nodal/Visceral Disease

Start date: 2008-06-01
Primary completion: 2009-07-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.